However, CD4+ percentage and CD4+/CD8+ ratio in these two groups were reduced compared to the controls, but with no significant differences between the two treatments, which indicated that although morphine-ketamine combination can attenuate cancer pain more effectively, the inhibitory effects on the levels of T cells are not enhanced. The gene discussed is CD4; the disease is cancer.